• Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • NSCLC
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • Type I Diabetes
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

Sebastian Seiguer, CEO of emocha Mobile Health, Discusses How Telehealth Services are Successfully Opening Schools and Managing Operations for Students, Staff

Podcast

In this week’s episode of Tuning Into the C-Suite podcast, MHE's Briana Contreras spoke with Sebastian Seiguer, CEO of emocha Mobile Health. The two talked about the key health challenges schools are facing as some are reopening across the country for the '20-'21 school year, how telehealth services like emocha are successfully using telehealth to open schools in a Return to Learn program, and paths forward for our nation’s largest school districts.

Sebastian Seiguer

To listen to more episodes featured on Tuning Into The C-Suite, visit us on Spotify, Apple Podcasts and iHeartRadio.


Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.